In this report we have raised the question whether genoto5dc carcinogens are more potent than nongenotoxk carcinogens when studied in long-tern carcinogenicity assays in rodents. To build a large database of compounds for which both carcinogenicity and genotoxicity had been investigated, we have used a database produced by Gold and co-workers for carcinogenic potency data (975 chemicals) and a database produced by Wurgler for genotoxicity data (2834chemicals). Con 
Introduction
In a recent work (I ), the capability of short-term tests in predicting carcinogenicity has been found to be much more limited than the estimates of previous assessments (2, 3) . Using equilibrated databases with similar numbers of genotoxic and nongenotoxic chemicals, assayed in short-term tests, and similar numbers ofcarcinogenic and noncarcinogenic chemicals assayed in rodent experiments, we could expect a 50% agreement of the two types of results just by chance. The actual level ofagreement observed by Tennant et al. in their study (1) was only approximately 60%.
In this work we wanted to investigate a different aspect of the relationship between genotoxicity and carcinogenicity. We thus asked the question: Are genotoxic carcinogens, on average, more potent and therefore more dangerous than nongenotoxic ones? As short-term tests for epigenetic and/or promoting activities are currently not available, we could expect that if carcinogenicity is a function of both genotoxicity and epigenetic-promoting activities, chemicals evaluated as genotoxic can have both activities, while chemicals evaluated as nongenotoxic can have at most have only one. Therefore, genotoxic chemicals, from the point of view of potential carcinogenicity, start with a kind of advantage in respect to nongenotoxic agents.
For both carcinogenicity and genotoxicity we have tried using a larger database to obtain a reasonably large intersection database between carcinogenicity studies and genotoxicity studies. We are aware that literature-based evaluations can be subjected to potential bias in favor ofeither clearly genotoxic or clearly carcinogenic compounds because it is sometimes easier to publish positive rather than negative results. We analyze this problem after presenting our results.
Methods and Results
As a database for carcinogenic potency, we used that of Gold et al. (4) (5) (6) . In this database, 975 chemicals are described, and 492 are defined as carcinogens (8) because tumor incidence in treated animals was found to be significantly higher than in control animals (in at least one target tissue or all tissues together), according to the conclusions of the authors of the experimental work. The other 483 chemicals can be defined as doubtful or negative and were not used in our study. As a database for genotoxicity, we used Wurgler's database (7) . In The database concerning our 113 compounds is shown in Table  1 . The compounds have a roughly log-normal distribution, as expected (10) .
In our database, we compared the carcinogenic potency of genotoxic and nongenotoxic carcinogens. The results obtained are shown in Table 3 . Table 3 clearly shows that genotoxic compounds are more potent than nongenotoxic ones. Genotoxic compunds are about 50 times more potent for information coming from at least three tests ( Fig. 1 ) and about 100 times more potent for information coming from at least six tests (Fig. 2) . In both cases the differences are statistically significant. (p < 0.0005).
To get an idea ofthe importance of the difference, we can consider the following: In Figure 1 , only about 8.2% of nongenotoxic carcinogens falls into the half to the left of the log-normal distribution of genotoxic carcinogens (the 50% most potent ones). This is true ifat leastthree short-term tests are considered. If at least six short-term tests are considered (Fig. 2) Table 3 ). The chemicals in Tennant's database were studied in a blind fashion; this is not the case for our database. Here we have two possibilities: a) a given chemical was already known to be a genotoxic agent. It is difficult in this case to envisage how this could have caused a bias by increasing the potency in the outcome of long-term experiments in rodents; b) the chemical was already known to be a carcinogen. If this caused a bias of heavily favoring the publication of positive data in terms of genotoxicity, most of the carcinogens of our database would be genotoxic, but we do not have a higher proportion of genotoxic carcinogens than Tennant et al. In conclusion, in our opinion, the fact that the chemicals of Tennant's database were tested blind cannot explain the discrepancies with our database.
We have also assessed whether the fact that in Wuirgler's database a much larger spectrum of short-term tests is considered than in Tennant's database could be partly responsible for the difference found between the two databases. For this purpose, to improve the correspondence between the short-term tests considered by us and Tennant we have used the pooled results obtained in Salmonella as a single test; considered the pooled results for sister chromatid exchanges as a single test; considered mammalian cytogenetics in vitro as a single test, and finally, used the mutagenicity data in mouse lymphoma L5178Y cells. With this restriction in the spectrum of short-term tests, we could define only 19 chemicals as genotoxic and only 5 chemicals as nongenotoxic. Genotoxic chemicals appeared, however, 192 times more potent than nongenotoxic ones.
To further explore the reasons for the observed differences we examined our intersection database and that of Tennant in terms of different chemical classes (Fig. 3) . The histogram in Figure  3 clearly shows that the two databases are rather different nitrosocompounds, nitrogen mustards, hydrazine derivatives, and polycyclic aromatic hydrocarbons are absent in Tennant Figure 4 .
Looking at Figure 4, Promoting and epigenetic effects are probably relevant carcinogenicity components both in rodents and in humans. Little is known about the extrapolability from rodents to humans of these kinds ofeffects. It is not even known if short-term in vitro tests for these types of effects will become technically possible in the near future. At present, we can most likely protect ourselves much better from the genotoxic component of carcinogenicity rather than from the promotion-epigenetic component. It is therefore important that studies to better assess the relevance to humans of nongenotoxic carcinogens be more thoroughly developed.
It seems, however, that for a completely new chemical, shortterm genotoxicity tests perform a useful task; not only do they inform us about one of the two major components of the carcinogenetic process (irreversible alterations in the genome), they also tend to detect a fraction of rather potent carcinogens. There are nongenotoxic carcinogens such as TCDD that are very potent, but this type ofepigenetic carcinogen is apparently rare. For a noncovalent interaction to induce a potent effect, a high affinity to a specific cellular receptor is expected. From a probabilistic point ofview, for a molecule unrelated to the conformation ofthe receptor itself, having good complementarity with a cellular receptor should be a rare event (12) .
Our results seem to modify the impression offered by the results of the work published by Tennant and co-workers (1). They seem to suggest that, even if short-term genotoxicity tests are not very good predictors of carcinogenicity in rodents because they can detect only a fraction ofthe factors that are relevant for the process of carcinogenesis, they are still useful because they tend to detect (as an average) the most potent carcinogens. This is equivalent to saying that even if irreversible alterations in the genome (genotoxic effects) are not the only component, they are still a very important (often the most important) component of the process of chemical carcinogenesis.
